Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure

Qin Huang, Young Kim, Amrita Krishnan, Nitya Nathwani, Stephen J. Forman, Chatchada Karanes, Eileen Smith, Eric L. Sievers, Sandra H. Thomas, Robert W. Chen, Young Kim

2012-02-28

SCID: 54.1/zpb3ergd

Abstract (AI)

Hodgkin lymphoma is considered highly curable, with approximately 70% of patients achieving long-term disease control using ABVD induction chemotherapy (adriamycin, bleomycin, vinblastine, dacarbaz...

Key Findings

Research Object

Research Subject

Publication Details

DOI

10.3109/10428194.2012.666543

Publication Date

2012-02-28

Journal

Publisher

ISSN

Access Type

Author Information

Authors

Qin Huang

Young Kim

Amrita Krishnan

Nitya Nathwani

Stephen J. Forman

Chatchada Karanes

Eileen Smith

Eric L. Sievers

Sandra H. Thomas

Robert W. Chen

Young Kim

Download PDF